Aponia Laboratories, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2010-01-01
- Employees
- 1
- Market Cap
- -
Controlled Study to Assess the Efficacy and Safety of S-Ibuprofen Topical Gel 5% (AP0302) in the Treatment of DOMS
Phase 2
Completed
- Conditions
- Pain, Acute
- Interventions
- Drug: S-IbuprofenDrug: Vehicle
- First Posted Date
- 2019-02-25
- Last Posted Date
- 2022-01-25
- Lead Sponsor
- Aponia Laboratories, Inc.
- Target Recruit Count
- 251
- Registration Number
- NCT03852459
- Locations
- 🇺🇸
JBR Clinical Research, Salt Lake City, Utah, United States
Phase II Study of AP0302 5% Versus a Vehicle Comparator
Phase 2
Completed
- Conditions
- PainDelayed Onset Muscle Soreness
- Interventions
- Drug: S-Ibuprofen Topical Gel 5%Drug: Vehicle Topical Gel
- First Posted Date
- 2014-12-24
- Last Posted Date
- 2019-02-25
- Lead Sponsor
- Aponia Laboratories, Inc.
- Target Recruit Count
- 147
- Registration Number
- NCT02324985
- Locations
- 🇺🇸
Lotus Clinical Research, LLC, Pasadena, California, United States
© Copyright 2025. All Rights Reserved by MedPath